2024
- Update on Disruption in Production of Intravenous (IV) Fluid Due to Impacts from Hurricane Helene – October 8, 2024
- Marburg Virus Disease Update – October 8, 2024
- Highly Pathogenic Avian Influenza and Pharmacist Influenza Testing – October 8, 2024
- Communicable Disease Updates – August 26, 2024
- Syphilis Treatment and Clinical Manifestations Updates for Providers – July 23, 2024
- Highly Pathogenic Avian Influenza Update for Virginia – May 3, 2024
- Reporting Adverse Events in Children Following Exposure to THC and CBD Containing Products – April 24, 2024
- Increase in Meningococcal Disease: Ongoing Statewide Outbreak and Local Detections of a Separate Antibiotic Resistant Strain – April 11, 2024
- Mobilizing HIV Clinicians to Vaccinate Vulnerable Virginians – February 22, 2024
- Mpox, Measles, and Sexually Transmitted Infection Prevention Updates for Virginia – February 13, 2024
- Increase in Mpox Cases in Virginia
- Stay Alert for Measles
- Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention
- Respiratory Disease Updates for Virginia – January 16, 2024
- CDC Advises Clinicians to Resume Using ACIP Recommendations for the Use of Nirsevimab
- Respiratory Immunization Rates in Virginia
- COVID-19 and Influenza Treatment Recommendations
- Expansion of Home Test to Treat Program
2023
- Mpox Updates for Virginia – December 11, 2023
- Democratic Republic of Congo Mpox Update
- VDH Recommendations for Providers
- Upcoming VDH Trainings for Providers
- Updated Syphilis Guidelines – November 28, 2023
- Respiratory Disease Updates for Virginia – November 15, 2023
- Immunizations Available to Protect Against Three Major Respiratory Illnesses
- FDA Advises Health Care Providers to Ensure Correct Moderna Vaccine Dosing
- CDC Provides Options for Clinicians in Response to a Limited Supply of Nirsevimab
- VDH Releases New Respiratory Disease Vaccine Dashboard and Weekly Activity Report
- COVID-19 Vaccine Updates for Virginia- September 15, 2023
- CDC Recommends 2023-2024 COVID-19 Vaccine Schedule
- Updates on COVID-19 Vaccine Commercialization
- Virginia Department of Health Declares Statewide Outbreak of Meningococcal Disease
- UPDATE: Shortage of Penicillin G Benzathine (Bicillin L-A)
- VDH Recommendations for Alternative Treatment Options
- Additional CDC Recommendations
- Additional Resources and Reference Materials for Clinicians
- Shortage of Penicillin G Benzathine (Bicillin L-A)
- VDH Recommendations for Alternative Treatment Options
- Additional CDC Recommendations
- Additional Resources and Reference Materials for Clinicians
- COVID-19 Updates for Virginia – April 25, 2023
- FDA authorizes and CDC Recommends Simplified COVID-19 Vaccine Schedule
- COVID-19 Update for Virginia – April 5, 2023
- Updates to Virginia’s COVID-19 Reporting Regulations
- CDC Recommends Updated Bivalent COVID-19 Booster for Certain Children Aged 6 Months through 4 Years
- COVID-19 Public Health Emergency to End on May 11, 2023
- Increase in Candida auris and Carbapenemase-producing Organisms
- Increase in Congenital Syphilis in 2022
- Meningococcal Disease Outbreak Update, Invasive Group A Strep Infections
2022
- Respiratory Illness Update – October 21, 2022
- Respiratory Syncytial Virus
- Influenza
- Ugandan Ebola Virus Disease Outbreak Update for Virginia – October 7, 2022
- Recommendations for Healthcare Providers
- COVID-19 and Monkeypox Updates for Virginia – October 6, 2022
- VDH Adopts CDC’s Revised COVID-19 Infection Prevention and Control Guidance
- Monkeypox Updates
- Meningococcal Outbreak in Eastern Region – September 23, 2022
- COVID-19 Update for Virginia – September 9
- CDC Recommends Updated COVID-19 Boosters
- Coadministration of COVID-19 and Other Vaccines
- EVUSHELD
- COVID-19 and Monkeypox Updates for Virginia – August 26
-
- CDC Updates COVID-19 Recommendations
- COVID-19 Vaccine Update: Novavax and Bivalent Boosters
- COVID-19 Therapeutic Update: Bebtelovimab is Available for Purchase Commercially
- Monkeypox Clinical Evaluation and Management
- JYNNEOS Vaccine for People at High Risk of Exposure to the Monkeypox Virus
- COVID-19 Update for Virginia – July 22
- EVUSHELD Dosing Schedule Change
- Paxlovid – Pharmacist Prescriptive Authority
- CDC Recommends Novavax COVID-19 Vaccine for Individuals Aged 18 Years and Older
- Monkeypox Updates
- CDC Health Alert Network: Recent Reports of Human Parechovirus (PeV) in the U.S.
- COVID-19 Update for Virginia – June 24
- CDC Recommends COVID-19 Vaccines for Children Aged 6 Months to 5 Years
- Pfizer-BioNTech (Pfizer) COVID-19 Vaccine
- Moderna COVID-19 Vaccine
- Additional information about the use of Pfizer and Moderna vaccines in young children
- CDC Recommends Moderna COVID-19 Vaccine for Children Aged 6 Through 17 Years
- Monkeypox Outbreak Update
- Monkeypox Update for Virginia – June 14
- COVID-19 Update for Virginia – May 20
- Infant Formula Shortage
- COVID-19
- Monkeypox
- Expected arrival of Ukrainian Refugees
- Acute Hepatitis with Unknown Etiology in Children – April 22
- COVID-19 Update for Virginia – April 5
- Second COVID-19 mRNA Vaccine Booster Doses
- COVID-19 Lab Reporting Updates
- HRSA Ending Reimbursement for COVID-19 Testing, Vaccines, and Therapeutics
- Possible FDA Deauthorization of Sotrovimab in Virginia
- COVID-19 Update for Virginia – March 10
- CDC COVID-19 Community Levels
- COVID-19 Therapeutics Update
- Consideration of Increased Interval Between 1st and 2nd Doses of mRNA Vaccines
- Prioritization of COVID-19 Antigen Testing Supplies
- List of Medical Conditions that Put People at Higher Risk for Severe COVID-19
- COVID-19 Update for Virginia – February 17
- CDC Updates Vaccine Recommendations for Immunocompromised Individuals and Those Who Received Passive Antibody Products
- FDA Grants Emergency Use Authorization to Bebtelovimab
- New Isolation and Quarantine Calculators
- National Blood Shortage
- COVID-19 Update for Virginia – February 10
- State Health Commissioner Issues Interim Guidelines for the Prioritization of the Use of Rapid COVID-19 Tests
- CDC Recommends FDA-Approved Moderna COVID-19 Vaccine
- Therapeutics Updates
- CDC and CMS Updates for Infection Prevention in Healthcare Settings
- Keeping Up With COVID Video Series
- COVID-19 Update for Virginia – January 11
- New Declaration of Limited State of Emergency in Virginia and Executive Order 84
- Updated Recommendations for COVID-19 Vaccines and Staying Up to Date
- Update on Omicron Surge and Therapeutics
- CDC Shortens Isolation and Quarantine Periods
2021
- COVID-19 Update for Virginia – December 29
- Updated and Shortened Isolation and Quarantine Guidance for the General Population
- Updated Guidance for the Management of Healthcare Personnel with SARS-CoV-2 Infection or Exposure
- Therapeutics Update
- COVID-19 Update for Virginia – December 20
- CDC Prefers mRNA Vaccines Over the Johnson & Johnson COVID-19 Vaccine
- Providers Required to Report All Immunizations to Virginia Immunization Information System Starting January 2022
- COVID-19 Update for Virginia – December 14
- Omicron (B.1.1.529) Variant Detected in Virginia
- COVID-19 Booster Doses Recommended for Everyone Aged 16 Years and Older
- COVID-19 Therapeutics Update
- Widespread Flu Activity in Virginia
- COVID-19 Update for Virginia – December 3
- Update on the Omicron Variant – Clarification added Dec. 7, 2021
- CDC’s Health Alert Network (HAN) Health Advisory About Increasing Seasonal Influenza A (H3N2)
- Upcoming Webinars on Monoclonal Antibodies and COVID-19 Vaccines
- COVID-19 Update for Virginia – November 22
- FDA and CDC Expand Eligibility for COVID-19 Booster Doses to All Adults
- CDC Updates Vaccine Guidance People Who Received COVID-19 Vaccine Outside the U.S. and People Who Received COVID-19 Vaccine as Part of a Clinical Trial
- Vaccine Administration Errors with Pediatric COVID-19 Vaccine
- VDH Releases New Monoclonal Antibody Locator Tool and Provides Additional Updates
- COVID-19 Update for Virginia – November 5
- Pfizer-BioNTech COVID-19 Vaccine Authorized and Recommended for 5–11 Year Olds
- COVID-19 Update for Virginia – October 28
- CDC Expands Eligibility for COVID-19 Booster Doses for Certain Recipients of Moderna and Johnson & Johnson COVID-19 Vaccines and Allows for Heterologous Booster Doses
- Update on Pfizer COVID-19 Vaccines for Children Aged 5 to 11 Years
- VDH Webinar on Understanding COVID-19 Vaccine: What the Evidence Tells Us
- VDH Statement on the Use of Ivermectin for the Prevention or Treatment of COVID-19
- COVID-19 Update for Virginia – September 30
- CDC Recommends a Booster Dose of Pfizer-BioNTech Vaccine Following a Primary Series for Certain Populations
- COVID-19 Vaccination and Pregnancy
- Vaccination for Children Aged 5 to 11 Years
- Update on Monoclonal Antibody Treatment for COVID-19 Distribution
- COVID-19 Updates for Virginia – September 20
- Back-to-School Resources and Reminders
- CDC’s Health Alert Network (HAN) Health Advisory about Ivermectin
- Update on Monoclonal Antibody Treatment for COVID-19
- Virginia Immunization Information System Requires All Immunizations January 2022
- Update on Measles in Virginia – September 14
- COVID-19 Update for Virginia – August 26
- FDA Grants Full Approval to Pfizer-BioNTech COVID-19 Vaccine
- Booster Dose of mRNA Vaccine for General Adult Population to Start in Mid-September
- Coadministration of COVID-19 and Influenza Vaccines
- Additional Updates about Respiratory Syncytial Virus
- COVID-19 Update for Virginia – August 16
- CDC Recommends an Additional Dose of mRNA Vaccine Following a Primary Series in Certain Immunocompromised People
- CDC Strengthens Vaccine Recommendation for People Who Are Pregnant, Breastfeeding, or Thinking of Becoming Pregnant
- VDH Reminds Clinicians of Testing and Masking Recommendations
- Health Commissioner Update – August 6
- Updates on the Delta (B.1.617.2) Variant and Guidance
- Monoclonal Antibody Therapy and Postexposure Prophylaxis
- Guillain-Barré syndrome after receiving Johnson & Johnson’s COVID-19 vaccine
- Updates about Non-COVID-19 Respiratory Viruses
- Burkholderia cepacia complex Infections Associated with Contaminated Ultrasound Gel
- Back-to-school Vaccinations and Updated Resources
- COVID-19 Update for Virginia – June 30
- Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination
- Monoclonal Antibody Update
- Updates on the Delta (B.1.617.2) and the Epsilon (B.1.427/B.1.429) Variants
- New CDC Viral Testing Tool
- Preparing for Heat-Related Illness
- COVID-19 Update for Virginia – May 14
- Updated CDC Guidance for Fully Vaccinated People
- Pfizer-BioNTech COVID-19 Authorized and Recommended for 12-15 Year Olds
- Importance of Not Missing COVID-19 Vaccination Opportunities
- Importance of Second Dose Administration of Pfizer-BioNTech and Moderna Vaccines
- Upcoming Webinar with a Pediatric COVID-19 Vaccination Expert Panel
- Importance of Testing Returning International Travelers and Encouraging Quarantine
- Candida auris Cases are on the Rise in Virginia – May 7
- COVID-19 Update for Virginia – April 7
- Importance of Diagnostic and Screening COVID-19 Testing in Virginia
- SARS-CoV-2 Variants
- Importance of Reporting COVID-19 Outbreaks
- Cases of Vaccine Breakthrough
- COVID-19 Update for Virginia – March 4
- Johnson & Johnson’s Janssen COVID-19 Vaccine
- Patient Outreach about COVID-19 Vaccination
- COVID-19 Vaccination Clinic Best Practices
- Updated Quarantine Recommendations for Fully Vaccinated People
- Work Restrictions for Exposed Healthcare Personnel
- Multisystem Inflammatory Syndrome in Children (MIS-C)
- SARS-CoV-2 Variants in Virginia
- Ebola Virus Disease Outbreaks in the Democratic Republic of Congo and Guinea
- COVID-19 Update for Virginia – January 25
- Required Information for COVID-19 Immunizations
- COVID-19 Vaccine Allocation Methodology
- B.1.1.7 Variant of COVID-19 Virus Detected in Virginia
- Travel Restrictions for People Entering the United States
- New Text Messaging Service to Streamline Positive Test Result Awareness and Exposure Notifications
- COVID-19 Update for Virginia – January 11
- Updates on COVID-19 Vaccine Prioritization for Phases 1b and 1c
- Submit your intent today to administer COVID-19 vaccine
- Enroll today to become a vaccination provider in Virginia’s Medical Reserve Corps
- FDA Communication: Genetic Variants of SARS-CoV-2 May Lead to False Negative Results with Molecular Tests for Detection of SARS-CoV-2
- FDA Safety Communication: Risk of False Results with the Curative SARS-CoV-2 Test for COVID-19
2020
- COVID-19 Update for Virginia – December 30
- COVID-19 Update for Virginia – December 21
- Urgent: Volunteers Needed for COVID-19 Vaccination Campaign – December 11
- COVID-19 Update for Virginia – December 7
- COVID-19 Update for Virginia – November 6
- COVID-19 Vaccine Provider Intent – October 2
- Face Coverings and Precautions During COVID-19 – September 18
- COVID-19 Update for Virginia – September 14
- COVID-19 Long-Term Care Update for Virginia – September 9
- COVID-19 Update for Virginia – August 7
- Acute Flaccid Myelitis – August 4
- COVID-19 Update for Virginia – July 13
- COVID-19 Update for Virginia – May 15
- COVID-19 Update for Virginia – May 7
- COVID-19 Update for Virginia – April 20
- COVID-19 Update for Virginia – April 4
- Treatment of COVID-19 – March 25
- Update on COVID-19 in Virginia – March 24
- COVID-19 in Virginia – March 13
- COVID-19 Update – March 6
- Update on COVID-19 – February 27
- Electronic Death Registration System – February 21
- 2019-nCoV– January 28
2019
- Reporting of Lung Injury Associated with Vaping – October 2
- Respiratory Illness and Vaping– August 20
- Candida auris – August 15
- Respiratory Illness – July 19
- Tick and Mosquito Infections – May 28
- Hepatitis A– April 25
Last Updated: October 8, 2024